Real Brands Enters Medical Psychedelics Market, Partners With Marcu & Arora For Licensure, R&D
Real Brands Inc. (OTCQB:RLBD) will become a premier provider of medical psychedelics. As Phase 1 of laying the groundwork, Real…
Miss Grass Cannabis Pre-Rolls To Reach Massachusetts And Illinois Via Partnership With AWH
Miss Grass has partnered with Ascend Wellness Holdings, Inc. (CSE: AAWH.U) (OTCQX: AAWH) to distribute its line of premium THC to Massachusetts and Illinois.
PSYC Corp. Reports Wider Net Loss In FY 2020 On Heels Of Name Change
PSYC Corporation (OTCP: PSYC), formerly known as Global Trac Solutions, Inc. and a company behind a psychedelic news and information platform Psychedelic Spotlight, reported its 2020 financials on Tuesday.
Psyched: MindCure Shuts Down Operations, Novamind And MindMed Partner For Study
The psychedelics space was shaken up on the news that MindCure Health (OTC:MCURF) was shutting down operations. After a…
NeonMind Files Provisional Patent Application For Psilocybin Induced Weight Loss
NeonMind Biosciences Inc. (OTCQB:NMDBF) (CSE:NEON) (FRA:6UF) has filed a new patent application with the U.S. Patent and Trademark…
Mycotopia Therapies Expands Supply Agreement With HAVN Life Sciences To Include Functional Mushrooms & Other Products
Mycotopia Therapies Inc. (OTC:TPIA) announced its plans to enter the $13 billion medicinal mushroom market with HAVN Life…
Understanding The Psilocybin Supply Chain: Every Production Method Explained
Psilocybin is known as the active compound in so-called “magic mushrooms”, yet most psilocybin used in clinical trials today is synthesized in laboratories without the use of biological material.
As psychedelics-assisted therapy gains momentum, investors need to understand the difference between the current available means of obtaining psilocybin.